Iain Tatt

Iain Tatt is currently the Access Evidence Lead in Global Access at Roche, where they apply their extensive knowledge of epidemiology to support business initiatives across various disease areas. With a strong methodological background in systematic reviewing and meta-analysis, Iain has established themselves as an internal expert in their field. They have previously held positions as a Clinical Scientist at Public Health Laboratory Service, a Senior Epidemiologist at GlaxoSmithKline, and have served in various roles at Roche since 2017. Iain earned a Ph.D. in Epidemiology from the University of Cambridge and holds a First Class B.Sc. in Genetics from the University of Nottingham, along with an M.Phil. in Epidemiology from the University of Cambridge.